Covaxin moves a step closer to WHO nod

Pre-submission meeting on Bharat Biotech’s EUL application slated for June 23

India’s vaccine against COVID-19 Covaxin is set to get closer to World Health Organization (WHO) approval with a pre-submission meeting for its emergency use listing scheduled for June 23 by the organisation. The meeting on the vaccine developed by Bharat Biotech is planned for June 23, a WHO document on the status of COVID-19 vaccines within EUL/PQ evaluation process and last updated on Thursday said. Bharat Biotech, which in association with Indian Council for Medical Research (ICMR) has developed the whole-virion inactivated vaccine, last month said the WHO approval was expected in the July-September quarter. The WHO had then said the application was submitted in April 19 and more information was needed. A pre-submission meeting was scheduled in May-June, the U.N. agency had said.